Your browser doesn't support javascript.
loading
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial.
Guigay, Joël; Ortholan, Cécile; Vansteene, Damien; Cupissol, Didier; Even, Caroline; Kaminsky, Marie-Christine; Sire, Christian; Blot, Emmanuel; Debourdeau, Philippe; Bozec, Laurence; Saada-Bouzid, Esma; Fayette, Jérôme; Dalloz, Pierre; Pointreau, Yoann; Caer, Hervé Le; Falandry, Claire; Digue, Laurence; Braccini, Antoine; Lopez, Stéphane; Guillet, Pierre; Michel, Cécile; Cheurfa, Nadir; Schwob, Dominique; Bourhis, Jean; Mertens, Cécile; Aupérin, Anne.
Affiliation
  • Guigay J; Partnerships and Clinical Development - Early Assets, GORTEC, Tours, France. Electronic address: joel.guigay@gortec.fr.
  • Ortholan C; Oncology-Radiotherapy Unit, Hospital Centre Princesse-Grace, Monaco.
  • Vansteene D; Medical Oncology Unit, West Cancerology Institute, Saint Herblain, France.
  • Cupissol D; Medical Oncology Unit, Cancer Institute of Montpellier, Montpellier, France.
  • Even C; Medical Oncology Unit, Gustave-Roussy Institute, Villejuif, France.
  • Kaminsky MC; Medical Oncology Unit, Lorraine Cancerology Institute, Nancy, France.
  • Sire C; Oncology-Radiotherapy Unit, Hospital Group South Bretagne, Lorient, France.
  • Blot E; Medical Oncology Unit, ELSAN Group, Private Hospital Océane, Vannes, France.
  • Debourdeau P; Medical Oncology Unit, Sainte Catherine Institute, Avignon, France.
  • Bozec L; Medical Oncology Unit, Curie Institute, Saint Cloud, France.
  • Saada-Bouzid E; Medical Oncology and Research Department, Centre Antoine Lacassagne, University Côte d'Azur, Nice, France.
  • Fayette J; Medical Oncology Unit, Cancer Research Centre Léon Bérard, Lyon, France.
  • Dalloz P; Medical Oncology Unit, Centre Jean Perrin, Clermont-Ferrand, France.
  • Pointreau Y; Radiation Oncology Unit, ILC (Inter-regional Cancerology Institute) - Jean Bernard Center & Victor Hugo Private Clinic, Sarthe Cancer Center, Le Mans, France.
  • Caer HL; Medical Oncology Unit, Hospital Centre of Saint-Brieuc, Saint-Brieuc, France.
  • Falandry C; Medical Oncology Unit, Hospital Centre of South Lyon, Pierre Bénite, France.
  • Digue L; Medical Oncology Unit, Saint André Universitary Hospital of Bordeaux, Bordeaux, France.
  • Braccini A; Medical Oncology Unit, Centre Azuréen de Cancérologie, Mougins, France.
  • Lopez S; Medical Oncology Unit, Hospital Centre of Annecy Genevois, Pringy, France.
  • Guillet P; Medical Oncology Unit, Intercommunal Hospital Centre, La Seyne sur Mer, France.
  • Michel C; Medical Oncology and Research Department, Centre Antoine Lacassagne, University Côte d'Azur, Nice, France.
  • Cheurfa N; Biostatistics and Epidemiology Unit, Gustave Roussy, Inserm U1018 Oncostat, Labelled Ligue Contre le Cancer, University Paris-Saclay, Villejuif, France.
  • Schwob D; Biostatistics and Epidemiology Unit, Gustave Roussy, Inserm U1018 Oncostat, Labelled Ligue Contre le Cancer, University Paris-Saclay, Villejuif, France.
  • Bourhis J; Radiotherapy Unit, Universitary Hospital Center of Vaudois, Lausanne, Switzerland.
  • Mertens C; Oncogeriatrics Unit, Bergonié Institute, Bordeaux, France.
  • Aupérin A; Biostatistics and Epidemiology Unit, Gustave Roussy, Inserm U1018 Oncostat, Labelled Ligue Contre le Cancer, University Paris-Saclay, Villejuif, France.
Lancet Healthy Longev ; 5(3): e182-e193, 2024 Mar.
Article in En | MEDLINE | ID: mdl-38432247
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Methotrexate / Head and Neck Neoplasms Limits: Aged / Female / Humans / Male Language: En Journal: Lancet Healthy Longev Year: 2024 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Methotrexate / Head and Neck Neoplasms Limits: Aged / Female / Humans / Male Language: En Journal: Lancet Healthy Longev Year: 2024 Document type: Article Country of publication: Reino Unido